Medical News

RSS

Intravenous infusion of HDL cholesterol could reduce risk of subsequent heart attack

An intravenous infusion of good cholesterol could reduce the risk of a subsequent heart attack, researchers reported at the American Heart Association's Scientific Sessions 2012.

6 Nov 2012

Adenovirus detection not uncommon among children with Kawasaki disease

Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.

5 Nov 2012

Study: Many Hispanic/Latino adults in the U.S. are at high risk for heart attack or stroke

A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.

5 Nov 2012

Researchers analyse hydrogen bonds in tiny fibrils of amyloid-beta peptide

Using solid-state nuclear magnetic resonance (NMR) spectroscopy, researchers at Luleå University of Technology in collaboration with Warwick University in the UK for the first time in the world managed to analyse hydrogen bonds in tiny fibrils of Amyloid-beta peptide , which probably causes Alzheimer's disease.

5 Nov 2012

Depomed third quarter 2012 revenue increases to $33.3 million

Depomed, Inc. today reported financial results for the quarter and nine months ended September 30, 2012.

5 Nov 2012

Inhibition of NOX4 enzyme plays an important role in liver fibrosis

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have led a study published in PLoS One showing that the inhibition of a family member of NADPH oxidase enzyme, NOX4, plays an important role in liver fibrosis.

5 Nov 2012

WHO’s Surgical Safety Checklist in the operating room reduces risks of perioperative mortality

The use of the World Health Organization's Surgical Safety Checklist in the operating room considerably lowers the risks of surgery.

5 Nov 2012

Tengion receives U.S. patent allowance titled ‘Isolated Renal Cells and Uses Thereof’

Tengion, Inc., a leader in regenerative medicine, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/617,721, titled "Isolated Renal Cells and Uses Thereof."

5 Nov 2012

No link between daily multivitamin use and reduction of major cardiovascular events in men

In a randomized study that included nearly 15,000 male physicians who were middle-aged or older, daily multivitamin use for more than 10 years of treatment and follow-up did not result in a reduction of major cardiovascular events, heart attack, stroke, or death from cardiovascular disease, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.

5 Nov 2012

Express Scripts reports net income of $391.4 million for third quarter 2012

Express Scripts announced 2012 third quarter net income of $391.4 million, or $0.47 per diluted share. Adjusted earnings per share, as detailed in Table 4 were $1.02 per diluted share for the third quarter.

5 Nov 2012

Gateway Aesthetic announces addition of three new procedures

The Gateway Aesthetic Institute & Laser Center in Salt Lake City, Utah is pleased to announce the addition of three new procedures to its broad list of available services in the aesthetics' arena.

5 Nov 2012

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.

5 Nov 2012

Affymetrix reports net loss of $17.9 million for third quarter 2012

Affymetrix, Inc., today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from eBioscience during the third quarter of 2012. This compares to total revenue of $64.0 million for the same period of 2011.

5 Nov 2012

Viewpoints: Romney, Obama offer details of their plans; The 'passionate supply-sider' who taught Paul Ryan; Medicare plan has not 'doomed GOP'

All presidential elections matter. This one matters a great deal. It matters to the senior who needs medical care but, thanks to ObamaCare, can't find a doctor who is taking new Medicare patients. ... This election is about them. It is about all of us. ... It is about the education of our children, the value of our homes, the take-home pay from our jobs, the price of the gasoline we buy, the choices we have in our health care.

5 Nov 2012